CARM·14216R101·US·equity·Healthcare - Biotechnology-Activist
CARM (CARISMA THERAPEUTICS INC) is held by 2 institutional investors as of Q4 2025. Largest holders: XTX Topco Ltd ($1,724), Empowered Funds, LLC ($1,332). Net institutional sentiment: Bearish.
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer